Forte Biosciences, Inc. (FBRX) DCF Valuation

Forte Biosciences, Inc. (FBRX) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Forte Biosciences, Inc. (FBRX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Discover the true potential of Forte Biosciences, Inc. (FBRX) with our advanced DCF Calculator! Adjust key variables, explore various scenarios, and evaluate how alterations affect the valuation of Forte Biosciences, Inc. (FBRX) – all within one comprehensive Excel template.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -4.1 -46.4 -21.5 -13.9 -32.5 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .0 .1 .0 .0 .0 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -4.1 -46.5 -21.5 -13.9 -32.5 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 6.9 58.8 42.0 41.1 37.1 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 1.6 1.2 .9 1.2 1.4 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -.2 .0 .0 .0 -.1 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -4.1 -78.5 -21.5 -13.9 -32.5 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -2.6 -78.8 -21.7 -13.7 -32.3 -1.4 .0 .0 .0 .0
WACC, % 11.32 11.32 11.32 11.32 11.32 11.32 11.32 11.32 11.32 11.32
PV UFCF
SUM PV UFCF -1.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -1
Net Debt -12
Equity Value 11
Diluted Shares Outstanding, MM 1
Equity Value Per Share 8.46

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real FBRX financials.
  • Real-World Data: Historical data and forward-looking estimates (as highlighted in the yellow cells).
  • Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Instantly observe the effect of your inputs on Forte Biosciences' valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.

Key Features

  • Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for Forte Biosciences, Inc. (FBRX).
  • WACC Calculator: Pre-configured Weighted Average Cost of Capital sheet with adjustable inputs specific to the biotech sector.
  • Customizable Forecast Assumptions: Adjust growth projections, capital expenditures, and discount rates according to market conditions.
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios for Forte Biosciences, Inc. (FBRX).
  • Interactive Dashboard and Charts: Visual representations provide a summary of essential valuation metrics for straightforward analysis.

How It Works

  • Download: Obtain the ready-to-use Excel file containing Forte Biosciences, Inc.'s (FBRX) financial data.
  • Customize: Modify forecasts such as revenue growth, EBITDA %, and WACC to suit your analysis.
  • Update Automatically: Enjoy real-time updates for intrinsic value and NPV calculations.
  • Test Scenarios: Generate various projections and instantly compare the results.
  • Make Decisions: Leverage the valuation outcomes to inform your investment approach.

Why Choose This Calculator for Forte Biosciences, Inc. (FBRX)?

  • User-Friendly Interface: Perfectly crafted for both novice and seasoned users.
  • Customizable Inputs: Adjust parameters easily to suit your analytical needs.
  • Real-Time Feedback: Observe immediate changes to Forte Biosciences’ valuation as you modify inputs.
  • Pre-Configured Data: Comes with Forte Biosciences’ actual financial metrics for swift evaluation.
  • Relied Upon by Experts: Favored by investors and analysts for making well-informed choices.

Who Should Use This Product?

  • Biotechnology Students: Explore drug development processes and analyze clinical trial data.
  • Researchers: Integrate advanced models into your studies or publications on biopharmaceuticals.
  • Investors: Validate your investment strategies and evaluate the market potential of Forte Biosciences, Inc. (FBRX).
  • Analysts: Enhance your analysis with a customizable financial model tailored for biotech companies.
  • Healthcare Professionals: Understand how public biotech firms like Forte Biosciences, Inc. (FBRX) are evaluated in the market.

What the Template Contains

  • Historical Data: Includes Forte Biosciences’ past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Forte Biosciences’ intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Forte Biosciences’ financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.